VERB vs. IH, STG, CHGG, HCMA, NAMI, AACG, YSXT, MRM, BEDU, and KUKE
Should you be buying Verb Technology stock or one of its competitors? The main competitors of Verb Technology include iHuman (IH), Sunlands Technology Group (STG), Chegg (CHGG), HCM Acquisition (HCMA), NAMI (NAMI), ATA (AACG), YSX Tech (YSXT), MEDIROM Healthcare Technologies (MRM), Bright Scholar Education (BEDU), and Kuke Music (KUKE). These companies are all part of the "personal services" industry.
Verb Technology vs. Its Competitors
iHuman (NYSE:IH) and Verb Technology (NASDAQ:VERB) are both small-cap personal services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.
iHuman has higher revenue and earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks.
In the previous week, Verb Technology had 6 more articles in the media than iHuman. MarketBeat recorded 6 mentions for Verb Technology and 0 mentions for iHuman. Verb Technology's average media sentiment score of 0.68 beat iHuman's score of 0.00 indicating that Verb Technology is being referred to more favorably in the news media.
4.9% of iHuman shares are held by institutional investors. Comparatively, 7.2% of Verb Technology shares are held by institutional investors. 63.6% of iHuman shares are held by company insiders. Comparatively, 0.6% of Verb Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
iHuman has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500. Comparatively, Verb Technology has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.
Verb Technology has a consensus price target of $62.00, indicating a potential upside of 327.59%. Given Verb Technology's stronger consensus rating and higher possible upside, analysts clearly believe Verb Technology is more favorable than iHuman.
iHuman has a net margin of 11.44% compared to Verb Technology's net margin of -235.87%. iHuman's return on equity of 11.00% beat Verb Technology's return on equity.
Summary
Verb Technology beats iHuman on 8 of the 15 factors compared between the two stocks.
Get Verb Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for VERB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VERB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Verb Technology Competitors List
Related Companies and Tools
This page (NASDAQ:VERB) was last updated on 8/31/2025 by MarketBeat.com Staff